PRELUDE CAPITAL MANAGEMENT, LLC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 85 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2020$84,0009,6670.01%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$9,431,886,00010.86%
Invus Financial Advisors, LLC 1,094,998$6,570,0001.51%
Founders Fund V Management, LLC 491,751$2,951,0000.16%
Arbor Wealth Management, LLC 25,888$155,0000.05%
PDT Partners, LLC 70,233$421,0000.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 575,443$3,453,0000.03%
NATIONS FINANCIAL GROUP INC, /IA/ /ADV 18,644$112,0000.02%
Fort Point Capital Partners LLC 10,000$60,0000.01%
Baillie Gifford 3,803,014$22,818,0000.01%
Summit Trail Advisors, LLC 13,458$81,0000.01%
View complete list of UNITY BIOTECHNOLOGY INC shareholders